All these findings provide an effective molecular skeleton for the discovery of LSD1 inhibitors, and sulphonamide based LSD1 inhibitors might be potentially anticancer drugs to treat bladder cancer. The gene discussed is KDM1A; the disease is urinary bladder cancer.